Can persistent peripheral immune activation promote neuroinflammation and cognitive dysfunction?

Persistent peripheral immune activation is a biologically credible contributor to brain inflammation and cognitive decline, but current human evidence supports association and mechanistic plausibility rather than proof of causation. This distinction is especially important when considering whether an infection explains cognitive symptoms.

Clinical and longitudinal evidence

• Prospective observational data suggest a modest relationship between inflammatory biomarkers and later cognitive decline. A meta-analysis of 19,516 participants found that elevated CRP, IL-6, or TNF-α was associated with 14% higher odds of subsequent decline; IL-6 showed the clearest subgroup association.
• Findings are not uniform across markers or cohorts. Higher IL-6 has been linked to longitudinal decline, whereas CRP, TNF-α, and other markers have shown inconsistent predictive value.
• A systematic review of 57 studies found no general association between past herpesvirus seropositivity and dementia. Recent infection or reactivation showed only tentative associations with dementia or mild cognitive impairment, with very low certainty.

Mechanistic interpretation

• Chronic circulating inflammatory signals may compromise the blood–brain barrier, increase exposure of the brain to peripheral mediators, and permit immune-cell entry. These processes can activate microglia and astrocytes, potentially sustaining inflammatory signaling, synaptic injury, and neuronal dysfunction.
• Peripheral inflammatory measures are not direct measures of neuroinflammation: in an Alzheimer-continuum cohort, TSPO-PET related to selected CSF inflammatory proteins but not plasma proteins.
• Seropositivity indicates prior exposure, not active infection or CNS involvement; peripheral reactivation likewise does not reliably demonstrate CNS reactivation.

Clinical implications

• With subacute or rapidly progressive decline, attribution to infection requires a compatible syndrome and objective CNS evidence—guided MRI, CSF testing, and targeted pathogen studies such as HSV/VZV PCR—while actively assessing alternative or coexisting causes.

Bottom line

• Persistent peripheral immune activation and infection may contribute to cognitive dysfunction through neuroinflammatory pathways, but neither establishes infection as the sole cause of cognitive decline.